Clinical Trial Update: Expanded Access for Use of ExoFlo in Abdominal Solid Organ Transplant Patients

View source ↗

Summary

This document reports an Expanded Access update for ExoFlo used in abdominal solid organ transplant patients. The program is listed as no longer available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Organ Transplant Rejection

Drugs mentioned

• ExoFlo

Snippet

Sponsor: Direct Biologics, LLC | Conditions: Solid Organ Transplant Rejection, Organ Rejection Transplants | Status: NO_LONGER_AVAILABLE